These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


570 related items for PubMed ID: 8639336

  • 1. A study on the epidemiology of hepatitis C infection among blood donors in Singapore.
    Wang JE.
    J Public Health Med; 1995 Dec; 17(4):387-91. PubMed ID: 8639336
    [Abstract] [Full Text] [Related]

  • 2. Association of HCV and Treponema pallidum infection in HIV infected northeastern Thai male blood donors.
    Barusrux S, Urwijitaroon Y, Puapairoj C, Romphruk A, Sriwanitchrak P.
    J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S106-11. PubMed ID: 9347656
    [Abstract] [Full Text] [Related]

  • 3. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK, Jork C, Schottstedt V, Weber-Schehl M, Brixner V, Busch MP, Geusendam G, Gubbe K, Mahnhardt C, Mayr-Wohlfart U, Pichl L, Roth WK, Schmidt M, Seifried E, Wright DJ, German Red Cross NAT Study Group.
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of viral markers among first-time Arab blood donors in Kuwait.
    Ameen R, Sanad N, Al-Shemmari S, Siddique I, Chowdhury RI, Al-Hamdan S, Al-Bashir A.
    Transfusion; 2005 Dec; 45(12):1973-80. PubMed ID: 16371052
    [Abstract] [Full Text] [Related]

  • 5. Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.
    Busch MP, Glynn SA, Stramer SL, Orland J, Murphy EL, Wright DJ, Kleinman S, NHLBI Retrovirus Epidemiology Donor Study (REDS) Group.
    Transfusion; 2006 Mar; 46(3):469-75. PubMed ID: 16533292
    [Abstract] [Full Text] [Related]

  • 6. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007.
    Kafi-abad SA, Rezvan H, Abolghasemi H, Talebian A.
    Transfusion; 2009 Oct; 49(10):2214-20. PubMed ID: 19527477
    [Abstract] [Full Text] [Related]

  • 7. Diversity and origin of hepatitis C virus infection among unpaid blood donors in the Netherlands.
    van de Laar TJ, Koppelman MH, van der Bij AK, Zaaijer HL, Cuijpers HT, van der Poel CL, Coutinho RA, Bruisten SM.
    Transfusion; 2006 Oct; 46(10):1719-28. PubMed ID: 17002628
    [Abstract] [Full Text] [Related]

  • 8. Hepatitis C virus infection among Thai blood donors: antibody prevalence, risk factors and development of risk screening form.
    Luksamijarulkul P, Thammata N, Sujirarat D, Tiloklurs M.
    Southeast Asian J Trop Med Public Health; 2004 Mar; 35(1):147-54. PubMed ID: 15272759
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of and risk factors for hepatitis B and C infection among Mongolian blood donors.
    Tserenpuntsag B, Nelson K, Lamjav O, Triner W, Smith P, Kacica M, McNutt LA.
    Transfusion; 2010 Jan; 50(1):92-9. PubMed ID: 19788639
    [Abstract] [Full Text] [Related]

  • 10. The risk of transfusion-acquired hepatitis-C virus infection among blood donors in Port Harcourt: the question of blood safety in Nigeria.
    Erhabor O, Ejele OA, Nwauche CA.
    Niger J Clin Pract; 2006 Jun; 9(1):18-21. PubMed ID: 16986284
    [Abstract] [Full Text] [Related]

  • 11. Patterns of age- and sex-specific prevalence of major blood-borne infections in United States blood donors, 1995 to 2002: American Red Cross blood donor study.
    Zou S, Notari EP, Stramer SL, Wahab F, Musavi F, Dodd RY, ARCNET Research Group.
    Transfusion; 2004 Nov; 44(11):1640-7. PubMed ID: 15504171
    [Abstract] [Full Text] [Related]

  • 12. Estimated risk of transmission of hepatitis C virus by blood transfusion.
    Koerner K, Cardoso M, Dengler T, Kerowgan M, Kubanek B.
    Vox Sang; 1998 Nov; 74(4):213-6. PubMed ID: 9691400
    [Abstract] [Full Text] [Related]

  • 13. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery.
    García-Bengoechea M, Emparanza JI, Sarriugarte A, Cortés A, Vega JL, González F, Arenas JI.
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):237-41. PubMed ID: 7538032
    [Abstract] [Full Text] [Related]

  • 14. Use of replacement blood donors to study the epidemiology of major blood-borne viruses in the general population of Maputo, Mozambique.
    Cunha L, Plouzeau C, Ingrand P, Gudo JP, Ingrand I, Mondlane J, Beauchant M, Agius G.
    J Med Virol; 2007 Dec; 79(12):1832-40. PubMed ID: 17935167
    [Abstract] [Full Text] [Related]

  • 15. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors.
    Hladik W, Kataaha P, Mermin J, Purdy M, Otekat G, Lackritz E, Alter MJ, Downing R.
    Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018
    [Abstract] [Full Text] [Related]

  • 16. [Anti-hepatitis C prevalence and incidence in 2.8 million blood donors in Lower Saxony--residual transfusion-associated HCV risk].
    Diekamp U, Kamutzky K, Windel CD.
    Beitr Infusionsther Transfusionsmed; 1997 Jun; 34():5-10. PubMed ID: 9417352
    [Abstract] [Full Text] [Related]

  • 17. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing.
    Zou S, Dorsey KA, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY, Stramer SL.
    Transfusion; 2010 Jul; 50(7):1495-504. PubMed ID: 20345570
    [Abstract] [Full Text] [Related]

  • 18. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C, Romanò L, Fomiatti L, Baruffi L, Zanetti AR, SIMTI Research Group.
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [Abstract] [Full Text] [Related]

  • 19. Risk factors for hepatitis C virus infection among blood donors in Beijing and implications for improving the pretesting donor screening process.
    Qiu Y, Shi L, Wang Y, Zhang G, Zheng J, Gong X, Xia H, Zhang P, Ness P, Shan H.
    Transfusion; 2008 Jun; 48(6):1207-12. PubMed ID: 18346015
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London.
    Mohsen AH, Murad S, Easterbrook PJ.
    HIV Med; 2005 May; 6(3):206-15. PubMed ID: 15876288
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 29.